Symbols

CCAP

Crescent Capital·NASDAQ

--(--)

CCAP fundamentals

CCAP Q4 2025 Earnings

Crescent Capital (CCAP) released its earnings on Feb 25, 2026: revenue was 40.80M (YoY -12.07%), beat estimates; EPS was 0.45 (YoY -18.18%), beat estimates.

Revenue / YoY

40.80M

-12.07%

EPS / YoY

0.45

-18.18%

Report date

Feb 25, 2026

CCAP Earnings Call Summary for Q4,2025

Dividend Sustainability: Q4 NII of $0.45 per share (107% dividend coverage) despite rate headwinds, with spillover income of $1.16 per share providing buffer.
Portfolio Resilience: 91% first lien loans, 99% sponsor-backed, and 71% with covenants. Q4 nonaccruals at 4.1% of cost, but January actions reduced pro forma to 1.4%.
Balance Sheet Strength: Debt-to-equity 1.25x, $242M undrawn capacity, and 2028+ maturity extension via $185M notes.
Strategic Review: Board evaluating dividend policy and fee structure for long-term alignment, with updates in Q1 2026.
Market Outlook: Spreads stabilizing at 475-500bps, cautious but improving LBO activity, and software portfolio generating strong cash flows.

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Crescent Capital (CCAP) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Crescent Capital (CCAP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Crescent Capital (CCAP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Crescent Capital (CCAP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown